Literature DB >> 9649555

Exacerbation of antigen-induced arthritis in urokinase-deficient mice.

N Busso1, V Péclat, K Van Ness, E Kolodziesczyk, J Degen, T Bugge, A So.   

Abstract

In rheumatoid arthritis, synovial expression of urokinase (uPA) activity is greatly increased (Busso, N., V. Péclat, A. So, and A. -P. Sappino. 1997. Ann. Rheum. Dis. 56:550- 557). We report the same effect in murine antigen-induced arthritis. uPA-mediated plasminogen activation in arthritic joints may have deleterious effects via degradation of cartilage and bone matrix proteins as well as beneficial effects via fibrin degradation. We evaluated these contrasting effects in vivo by analyzing the phenotype of uPA-deficient (uPA-/-) and control mice during antigen-induced arthritis. Joint inflammation was comparable in both groups up to day 3 and subsequently declined in control mice, remaining significantly elevated in uPA-/- mice on days 10 and 30 after arthritis onset. Likewise, synovial thickness was markedly increased in uPA-deficient mice persisting for up to 2 mo, whereas it subsided in control animals. Bone erosion was exacerbated in uPA-/- mice on day 30. By contrast, no difference in articular cartilage proteoglycan content was found between both groups. Significantly increased accumulation of fibrin was observed by day 30 in arthritic joints of uPA-/- mice. We hypothesized that synovial fibrin deposition plays a role in joint inflammation. Accordingly, defibrinogenation of uPA-/- mice by ancrod significantly decreased the sustained joint inflammation. All the above observations were reproducible in plasminogen-deficient (Pln-/-) mice. In conclusion, synovial fibrin deposition plays a role as a nonimmunological mechanism which sustains chronic arthritis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649555      PMCID: PMC509063          DOI: 10.1172/JCI2312

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  The production of arthritis in rabbits by an immunological reaction to fibrin.

Authors:  D C DUMONDE; L E GLYNN
Journal:  Br J Exp Pathol       Date:  1962-08

Review 2.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

3.  A novel technique for immunohistoperoxidase staining of unfixed whole joints of small animals.

Authors:  S C Meacock; D R Brandon; C P Brown; B P Swann
Journal:  Histochem J       Date:  1992-02

Review 4.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

5.  Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.

Authors:  J B Weinberg; A M Pippen; C S Greenberg
Journal:  Arthritis Rheum       Date:  1991-08

6.  Studies of the metabolism and distribution of fibrinogen in patients with rheumatoid arthritis.

Authors:  Y Takeda
Journal:  J Lab Clin Med       Date:  1967-04

7.  Amiloride selectively inhibits the urokinase-type plasminogen activator.

Authors:  J D Vassalli; D Belin
Journal:  FEBS Lett       Date:  1987-04-06       Impact factor: 4.124

8.  Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice.

Authors:  A König; R C Mühlbauer; H Fleisch
Journal:  J Bone Miner Res       Date:  1988-12       Impact factor: 6.741

9.  Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.

Authors:  A P Sappino; J Huarte; J D Vassalli; D Belin
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Effects of tumor necrosis factor alpha and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes.

Authors:  I K Campbell; D S Piccoli; M J Roberts; K D Muirden; J A Hamilton
Journal:  Arthritis Rheum       Date:  1990-04
View more
  48 in total

1.  Identification of potential serum biomarkers for rheumatoid arthritis by high-resolution quantitative proteomic analysis.

Authors:  Yongjing Cheng; Yuling Chen; Xiaolin Sun; Yuhui Li; Cibo Huang; Haiteng Deng; Zhanguo Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  Roles for thrombin and fibrin(ogen) in cytokine/chemokine production and macrophage adhesion in vivo.

Authors:  Frank M Szaba; Stephen T Smiley
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 3.  Fibrinogen Is at the Interface of Host Defense and Pathogen Virulence in Staphylococcus aureus Infection.

Authors:  Ya-Ping Ko; Matthew J Flick
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

Review 4.  Rodent models of arthritis: relevance for human disease.

Authors:  R O Williams
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

5.  Coagulation takes center stage in inflammation.

Authors:  Katerina Akassoglou
Journal:  Blood       Date:  2015-01-15       Impact factor: 22.113

6.  Amelioration of collagen-induced arthritis by thrombin inhibition.

Authors:  I Marty; V Péclat; G Kirdaite; R Salvi; A So; N Busso
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

7.  The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis.

Authors:  Jinan Li; Annelii Ny; Göran Leonardsson; Kutty Selva Nandakumar; Rikard Holmdahl; Tor Ny
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice.

Authors:  Rikke Stagaard; Carsten Dan Ley; Kasper Almholt; Lisbeth Høier Olsen; Tom Knudsen; Matthew J Flick
Journal:  Blood Adv       Date:  2018-11-27

9.  Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Authors:  Andrew D Cook; Christine M De Nardo; Emma L Braine; Amanda L Turner; Ross Vlahos; Kerrie J Way; S Kaye Beckman; Jason C Lenzo; John A Hamilton
Journal:  Arthritis Res Ther       Date:  2010-03-02       Impact factor: 5.156

10.  Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.

Authors:  Harini Raghu; Alice Jone; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Jay L Degen; Matthew J Flick
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.